Regencell Bioscience Holdings Limited (RGC) vs Tango Therapeutics, Inc. (TNGX)
A side-by-side comparison of Regencell Bioscience Holdings Limited and Tango Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
RGC
Regencell Bioscience Holdings Limited
$7.71HealthcareDelayed quote: Oct 6, 2026, 2:17 PM EDT
TNGX
Tango Therapeutics, Inc.
$21.57HealthcareDelayed quote: Oct 6, 2026, 2:20 PM EDT
Total return — RGC vs TNGX
growth of $100 · dividends reinvested · last 5yRGC +2520.2% (+92.2%/yr)TNGX +115.1% (+16.6%/yr)RGC compounded faster over this window
Log scale — wide-divergence pair
RGC TNGX
RGC vs TNGX: by the numbers
- •RGC is the larger company ($3.82B vs $3.51B market cap).
- •Both run net losses; RGC's is the smaller (0.00% vs -229.92% net margin).
Metrics side by side
Valuation
| Metric | RGC | TNGX |
|---|---|---|
| P/S ratio | N/A | 65.26 |
| P/B ratio | 3132.82 | 3.43 |
Profitability
| Metric | RGC | TNGX |
|---|---|---|
| Gross margin | 0.00% | 98.25% |
| Operating margin | 0.00% | -178.39% |
| Net margin | 0.00% | -229.92% |
| ROE | -73.75% | -12.08% |
| ROIC | -69.75% | -12.91% |
Growth (annualized)
| Metric | RGC | TNGX |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 19.14% |
| Total return CAGR (5Y) | 67.94% | 10.60% |
Frequently asked
- How have RGC and TNGX total returns compared?
- Over the past 5 years, RGC delivered 67.94% and TNGX delivered 10.60% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Regencell Bioscience ROETango Therapeutics ROERegencell Bioscience operating marginTango Therapeutics operating marginRegencell Bioscience revenue growthTango Therapeutics revenue growthRegencell Bioscience free cash flowTango Therapeutics free cash flow
Regencell Bioscience & Tango Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.